CIK 0001817713
- Large accelerated filer
Janux Therapeutics, Inc.
Sign in to watch- Ticker
- JANX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 822289112
- Phone
- +1 858-751-4493
- Business address
- 10955 VISTA SORRENTO PARKWAY, SUITE 200, SAN DIEGO, CA, 92130
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 38 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-11-05 | CAPPS VICKIE L Director | Other acquisition | +2,305 | 70,348 | ||
| 2024-10-28 | Campbell David Alan President and CEO | Sale 10b5-1 | −13,897 | $53.22 | $740K | 293,157 |
| 2024-10-28 | Campbell David Alan President and CEO | Sale 10b5-1 | −11,103 | $53.94 | $599K | 282,054 |
| 2024-10-18 | RA CAPITAL MANAGEMENT, L.P. Director | Purchase | +1,200,000 | $44.75 | $53.7M | 9,317,246 |
| 2024-10-18 | Avalon Ventures XI, L.P. 10% owner | Sale | −102,732 | $50.30 | $5.2M | 2,629,085 |
| 2024-10-18 | Avalon Ventures XI, L.P. 10% owner | Sale | −19,900 | $50.30 | $1.0M | 509,273 |
| 2024-10-18 | Avalon Ventures XI, L.P. 10% owner | Sale | −104,892 | $50.30 | $5.3M | 2,684,380 |
| 2024-10-18 | Avalon Ventures XI, L.P. 10% owner | Sale | −15,462 | $51.18 | $791K | 2,613,623 |
| 2024-10-18 | Avalon Ventures XI, L.P. 10% owner | Sale | −2,995 | $51.18 | $153K | 506,278 |
| 2024-10-18 | Avalon Ventures XI, L.P. 10% owner | Sale | −15,788 | $51.18 | $808K | 2,668,592 |
| 2024-10-18 | Avalon Ventures XI, L.P. 10% owner | Sale | −541,824 | $44.75 | $24.2M | 2,071,799 |
| 2024-10-18 | Avalon Ventures XI, L.P. 10% owner | Sale | −104,957 | $44.75 | $4.7M | 401,321 |
| 2024-10-18 | Avalon Ventures XI, L.P. 10% owner | Sale | −553,219 | $44.75 | $24.8M | 2,115,373 |
| 2024-10-17 | Avalon Ventures XI, L.P. 10% owner | Option exercise | +836 | $17.00 | $14K | 7,281 |
| 2024-10-17 | Avalon Ventures XI, L.P. 10% owner | Option exercise | +348 | $10.73 | $4K | 7,629 |
| 2024-10-17 | Avalon Ventures XI, L.P. 10% owner | Option exercise | +348 | $13.22 | $5K | 7,977 |
| 2024-10-17 | Avalon Ventures XI, L.P. 10% owner | Option exercise | +237 | $39.80 | $9K | 8,214 |
| 2024-10-17 | Avalon Ventures XI, L.P. 10% owner | Sale | −1,843 | $50.02 | $92K | 6,371 |
| 2024-10-17 | Avalon Ventures XI, L.P. 10% owner | Option exercise · Stock Option (right to buy) | −836 | 21,940 | ||
| 2024-10-17 | Avalon Ventures XI, L.P. 10% owner | Option exercise · Stock Option (right to buy) | −348 | 9,142 |
Page 7 of 15 · 294 trades